van Werkum Jochem W, Heestermans Antonius A, Zomer A Carla, Kelder Johannes C, Suttorp Maarten-Jan, Rensing Benno J, Koolen Jacques J, Brueren B R Guus, Dambrink Jan-Henk E, Hautvast Raymond W, Verheugt Freek W, ten Berg Jurriën M
Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
J Am Coll Cardiol. 2009 Apr 21;53(16):1399-409. doi: 10.1016/j.jacc.2008.12.055.
This study sought to comprehensively identify predictors of stent thrombosis (ST).
Given the devastating consequences of ST, efforts should be directed toward risk stratification to identify patients at highest risk for ST.
Consecutive patients with angiographic ST were enrolled. Patients who did not suffer from a ST were randomly selected in a 2:1 ratio and were matched for: 1) percutaneous coronary intervention (PCI) indication; 2) same date of index PCI; and 3) same interventional center.
Of 21,009 patients treated with either a bare-metal or drug-eluting stent, 437 patients (2.1%) presented with a definite ST. A total of 140 STs were acute, 180 were subacute, 58 were late, and 59 were very late. Undersizing of the coronary stent, Thrombolysis In Myocardial Infarction flow grade <3, present malignancy, presence of intermediate coronary artery disease proximal and distal to the culprit lesion, dissection, lack of aspirin, bifurcation lesions, ejection fraction <30%, and younger age were associated with ST. The lack of clopidogrel therapy at the time of ST in the first 30 days after the index PCI (hazard ratio [HR]: 36.5, 95% confidence interval [CI]: 8.0 to 167.8), between 30 days and 6 months after the index PCI (HR: 4.6, 95% CI: 1.4 to 15.3), and beyond 6 months (HR: 5.9, 95% CI: 1.7 to 19.8) after the index PCI was strongly associated with ST.
Important correlates of ST were identified. Discontinuation of clopidogrel, undersizing of the coronary stent, present malignancy, and intermediate (>or=50% to <70% stenosis) coronary artery disease proximal to the culprit lesion were the strongest predictors of ST.
本研究旨在全面识别支架内血栓形成(ST)的预测因素。
鉴于ST的严重后果,应致力于进行风险分层,以识别ST风险最高的患者。
纳入连续的血管造影确诊为ST的患者。未发生ST的患者按2:1的比例随机选取,并在以下方面进行匹配:1)经皮冠状动脉介入治疗(PCI)指征;2)首次PCI日期相同;3)介入中心相同。
在21009例接受裸金属支架或药物洗脱支架治疗的患者中,437例(2.1%)出现明确的ST。共有140例ST为急性,180例为亚急性,58例为晚期,59例为极晚期。冠状动脉支架尺寸过小、心肌梗死溶栓治疗血流分级<3、存在恶性肿瘤、罪犯病变近端和远端存在中度冠状动脉疾病、夹层、未使用阿司匹林、分叉病变、射血分数<30%以及年龄较小与ST相关。在首次PCI后30天内发生ST时未使用氯吡格雷治疗(风险比[HR]:36.5,95%置信区间[CI]:8.0至167.8)、在首次PCI后30天至6个月之间(HR:4.6,95%CI:1.4至15.3)以及首次PCI后6个月以上(HR:5.9,95%CI:1.7至19.8)与ST密切相关。
确定了ST的重要相关因素。氯吡格雷停药、冠状动脉支架尺寸过小、存在恶性肿瘤以及罪犯病变近端的中度(≥50%至<70%狭窄)冠状动脉疾病是ST最强的预测因素。